Sept. 3, 2026 — Royal Philips has introduced the eV14-2v transvaginal transducer, expanding its obstetrics and gynecology ultrasound portfolio. FDA 510(k) cleared and CE marked, the eV14-2v is designed to support a broad range of gynecology and early obstetrics exams by combining image quality and broad clinical capabilities in a single lightweight transducer.

Sept. 2, 2026 – Sonex Health and The Institute of Advanced Ultrasound Guided Procedures have announced publication of final two-year data demonstrating the safety and efficacy of ultrasound-guided carpal tunnel release (UGCTR) using UltraGuideCTR in an office-based procedure.

Sept. 1, 2026 — On Sept. 24, 2026 at 1 p.m. EDT, Siemens Healthineers will present a webinar on "Advancing Women's Health with Molecular Imaging: A Novel Radiotracer for ER-Positive Breast Cancer."

The webinar will be presented by Dr. Annie Packard, M.D., Mayo Clinic, Rochester, Minn.

Sept. 2, 2026 — Children with one of the deadliest forms of brain cancer may benefit from an additional course of radiation therapy after their disease returns, according to new research from the Icahn School of Medicine at Mount Sinai. The study, published in Practical Radiation Oncology (10.1016/j.prro.2026.06.006), is the first to examine the experience of giving three courses of radiation treatment to patients with diffuse intrinsic pontine glioma (DIPG) that has recurred.

Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital, that evaluated the investigational positron emission tomography (PET) radiotracer iodine 124 evuzamitide (I 124 evuzamitide) for the diagnosis of cardiac amyloidosis.1 

Sept. 1, 2026— A new study from the Harvey L. Neiman Health Policy Institute found that the odds of imaging following an office visit were 188% higher when ordering clinician self-interpreted the imaging they ordered versus referring interpretation to a radiologist. Practices that routinely referred imaging to a radiologist also demonstrated lower imaging use following office visits. The study, based on 24.2 million Medicare office visits, was published in the Journal of the American College of Radiology (JACR).

Aug. 31, 2026 — GE HealthCare recently achieved the CE Mark for Photonova Spectra1, an advanced photon-counting computed tomography (PCCT) system with the company’s proprietary Deep Silicon detector technology. This expands access and enables clinical adoption of the technology in CE Mark–observing countries.

Aug. 26, 2026 — ROPCA, a Danish medtech company developing robotic and AI-powered solutions for musculoskeletal ultrasound, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Arthur, an AI-powered, fully autonomous ultrasound robot, and ROPCA's AI software Diana, marking a major milestone in the company’s expansion into the U.S. healthcare market.

Aug. 27, 2026 — Noah Medical recently announced that its Galaxy System is now fully compatible with GE HealthCare’s premium OEC C-arm portfolio, enabling seamless integration for image-guided, robotic-assisted bronchoscopy, marking a significant step forward in expanding access to precise, minimally invasive lung diagnostics.

Aug. 26, 2026 — AMRA Medical has announced the publication of new research in Neurology demonstrating the potential of quantitative whole-body MRI to measure disease progression in Spinal and Bulbar Muscular Atrophy (SBMA), a rare, progressive neuromuscular disease. The research was also selected for the cover of the issue, providing additional visibility for this important work in neuromuscular disease research.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now